Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia
- Authors: Sharkunov NN1, Moiseeva TN1, Zybunova EE1, Vinogradova OI.1, Kravchenko SK1
-
Affiliations:
- ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
- Issue: Vol 84, No 11 (2012)
- Pages: 71-74
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31153
- ID: 31153
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N N Sharkunov
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: nsharkunov1985@mail.ru
125167 Москва, Новый Зыковский проезд, 4
T N Moiseeva
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: taniamoiseeva@mail.ru
E E Zybunova
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: see58@mail.ru
O Iu Vinogradova
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: olgavinz@mail.ru
S K Kravchenko
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: krav@blood.ru
References
- Симбирцева Л.П., Холсти Л. Лимфогранулематоз. М: Медицина 1985.
- Jaffe E., Harris N., Stein H., Lyon V.J. IACR Press 2001.
- DeVita V.T. (eds.), Hellman S., Rosenberg S.A. Cancer: Principles & Practice of Oncology. 6th ed. Vol. 2. Philadelphia: Lippincott - Raven Publishers 2001.
- Ries L.A.G., Miller B.A., Hankey B.F. National Cancer Institute. NIH Publication Number 94 1994.
- Двойрин В.В., Аксель Е.М., Трапезников Н.Н. Статистика злокачественных новообразований в России и некоторых других странах СНГ. М 1995.
- Kaplan H.S. Hodgkin's Disease. Cambridge: Harvard University Press 1980.
- Parkin D.M., Muir C.S., Whelan S.L. et al. Scientific Publications N120. Lyon: International Agency for Research on Cancer 1992.
- Ramanarayanan J., Dunford L.M., Baer M.R. et al. Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients. Leuk Res 2006; 30: 6: 701-705.
- Aguiar R.C. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 1998; 29: 1-2: 17-26.
- Wintrobe M.M. Tumors and Tumorlike Conditions Involving the Blood-forming Organs in Clinical Hematology, 5th Ed., Lea & Febiger, Philadelphia 1961: 1004-1095.
- Greenstein R.H., Conston A.S. Coexistent Hodgkin's disease and Kaposi's sarcoma: Report of a case with unusual clinical features. Am J Med Sci 1949; 218: 384.
- Greenberg B.B., Stats D., Goldberg M. Simultaneous occurrence of plasma cell myeloma and Hodgkin's Disease, NY J Med 1950; 50: 305.
- Lalayanni C., Theodoridou S., Athanasiadou A. et al. Simultaneous occurrence of multiple myeloma and Hodgkin's disease. A case report. Haematologica 2000; 85: 7: 772-773.
- Moertel C.G., Hagedorm A.B. Leukemia or lymphoma and coexistent primary malignant lesions: A review of the literature and a study of 120 cases. Blood 1957; 12: 788.
- Nandakumar A., Davis S., Moolgavkar S. et al. Myeloid leukaemia following therapy for a first primary cancer. Br J Cancer 1991; 63: 782-788.
- Kaldor J.M., Day N.E., Clarke E.A. et al. Leukemia following Hodgkin's disease. N Engl J Med 1990; 322: 1: 7-13.
- Fava C., Cortés J.E., Kantarjian H., Jabbour E. Standard management of patients with chronic myeloid leukemia. Clin Lymphoma Myeloma 2009; 9 (Suppl 4): 382-390.
- Ferrario A., Radaelli F., Goldaniga M. et al. ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma. Leuk Res 2010; 34: 10: 280-281.
- Renné C., Hansmann M.L., Bräuninger A. Receptor tyrosine kinases in Hodgkin lymphoma as possible therapeutic targets. Pathologe 2009; 30: 5: 393-400.
- Renné C., Willenbrock K., Küppers R. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood 2005; 105: 10: 4051-4059.
![](/img/style/loading.gif)